Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP848971.RAtR7JEp2TfAo5-OZw1yB2ibhtvlGLKHo-lI6V1LNhZBU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP848971.RAtR7JEp2TfAo5-OZw1yB2ibhtvlGLKHo-lI6V1LNhZBU130_assertion type Assertion NP848971.RAtR7JEp2TfAo5-OZw1yB2ibhtvlGLKHo-lI6V1LNhZBU130_head.
- NP848971.RAtR7JEp2TfAo5-OZw1yB2ibhtvlGLKHo-lI6V1LNhZBU130_assertion description "[Taken together our data suggests that EBBP acts to de-repress transcription of RARbeta2 and CYP26A1, by modifying histone acetylation in retinoid-resistant cancer cells, and, is an important target for drug discovery in retinoid-resistant cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848971.RAtR7JEp2TfAo5-OZw1yB2ibhtvlGLKHo-lI6V1LNhZBU130_provenance.
- NP848971.RAtR7JEp2TfAo5-OZw1yB2ibhtvlGLKHo-lI6V1LNhZBU130_assertion evidence source_evidence_literature NP848971.RAtR7JEp2TfAo5-OZw1yB2ibhtvlGLKHo-lI6V1LNhZBU130_provenance.
- NP848971.RAtR7JEp2TfAo5-OZw1yB2ibhtvlGLKHo-lI6V1LNhZBU130_assertion SIO_000772 19147277 NP848971.RAtR7JEp2TfAo5-OZw1yB2ibhtvlGLKHo-lI6V1LNhZBU130_provenance.
- NP848971.RAtR7JEp2TfAo5-OZw1yB2ibhtvlGLKHo-lI6V1LNhZBU130_assertion wasDerivedFrom befree-20150227 NP848971.RAtR7JEp2TfAo5-OZw1yB2ibhtvlGLKHo-lI6V1LNhZBU130_provenance.
- NP848971.RAtR7JEp2TfAo5-OZw1yB2ibhtvlGLKHo-lI6V1LNhZBU130_assertion wasGeneratedBy ECO_0000203 NP848971.RAtR7JEp2TfAo5-OZw1yB2ibhtvlGLKHo-lI6V1LNhZBU130_provenance.